Technology Transfer Mission and Objectives

Roswell Park Cancer Institute (RPCI), America's first cancer center, was founded in 1898 by Dr. Roswell Park. His revolutionary model of a multidisciplinary approach to cancer — with scientists and clinicians working in concert — has become a standard for all modern-day comprehensive cancer centers.

RPCI is among the first and only upstate New York facilities to hold the National Cancer Institute designation of Comprehensive Cancer Center and to serve as a member of the National Comprehensive Cancer Network.

Over the last decade, RPCI has undergone major growth, adding over 1,000 new jobs, initiating one of the nation’s first hospital facilities dedicated to Phase I cancer research studies, and setting itself apart as a leader in surgical robotics, vitamin D research, immunotherapy and vaccine therapy, tumor microenvironment and cancer prevention studies, and the development and testing of new agents and technology.

Roswell Park recognizes that it takes external business relationships to ultimately translate its discoveries into useful patient therapies and is looking to partner, collaborate and license out its research to further its mission.

Mission Statement

The Technology Transfer Office works with basic and clinical researchers to assess market opportunities, secure intellectual property protection, negotiate partnering/licensing arrangements, and assist in the commercialization process.

Technology Transfer Objectives

  • Translation of research into human health improvement
  • Faculty recruitment incentives
  • Local economic development
  • Licensing royalties into Roswell Park

What We Do

  • Evaluate commercial opportunities and market potential for new intellectual property
  • Protect Roswell Park intellectual property through patent applications and prosecution and copyright registration
  • Market intellectual property — View the technologies currently available for licensing and collaboration
  • Negotiate license agreements and options
  • Execute crucial agreements, including material transfer, confidentiality, interinstitutional, and research collaboration
  • Review intellectual property language in sponsored research and clinical trial agreements
  • Monitor licensee compliance
  • Track milestones and collect royalties
  • Distribute payments to inventors and authors, labs, departments, centers, institutes, and departments
  • Support new startup activity and entrepreneurship